Avenanthramide A triggers potent ROS-mediated anti-tumor effects in colorectal cancer by directly targeting DDX3
Published:1 August 2019
DOI: 10.1038/s41419-019-1825-5
Rong Fu,?Peng Yang,?Zongwei Li,?Wen Liu,?Sajid Amin,?Zhuoyu Li
Abstract